Clinical trial
Uterine Papillary Serous Cancer (UPSC) Trial
NCT00147680 · Queensland Centre for Gynaecological Cancer, Other · Completed
Key facts
| NCT number | NCT00147680 |
|---|---|
| Title | Uterine Papillary Serous Cancer (UPSC) Trial |
| Official title | Prospective, Non-randomised Phase 2 Clinical Trial of Carboplatin Plus Paclitaxel With Sequential Radical Pelvic Radiotherapy for Uterine Serous Papillary Cancer |
| Lead sponsor | Queensland Centre for Gynaecological Cancer, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Carboplatin |
| Enrollment | 30 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Sep 7, 2005 |
| Last update posted | Feb 2, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: